OxThera OxThera
  • About Us
    • Message from the CEO
    • About Us
    • Leadership Team and Strategic Advisor
    • Board of Directors
    • FAQs
  • Hyperoxaluria
  • Pipeline
  • Clinical
  • Investors
    • Market Opportunity
    • Current Investors
  • Media
    • Press Releases
    • Contact Us

MEDIA

Press Releases

Contact Us

Backed by an Industry-Savvy Board

Board of Directors
OxThera_logo

Regeringsgatan 111, SE-111 39
Stockholm, Sweden

245 Crowfield Road
Knoxville, Tennessee 37922, United States

Stay in Touch
Phone: +46 8 660 02 23
Email: info@oxthera.com
Contact Us

© OxThera. All Rights Reserved

Trademarks: The following trademarks are owned and protected by OxThera and should not be misused or referred to incorrectly: OXTHERA, OXABACT, OXAZYME.

Logo
  • About Us
    • Message from the CEO
    • About Us
    • Leadership Team and Strategic Advisor
    • Board of Directors
    • FAQs
  • Hyperoxaluria
  • Pipeline
  • Clinical
  • Investors
    • Market Opportunity
    • Current Investors
  • Media
    • Press Releases
    • Contact Us